Exelixis
EXEL
#1757
Rank
A$17.08 B
Marketcap
A$63.47
Share price
-4.94%
Change (1 day)
15.49%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: A$17.08 Billion

As of December 2025 Exelixis has a market cap of A$17.08 Billion. This makes Exelixis the world's 1757th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025A$17.08 B10.06%
2024A$15.52 B41.76%
2023A$10.95 B44.02%
2022A$7.60 B-4.7%
2021A$7.97 B-1.48%
2020A$8.09 B5.9%
2019A$7.64 B-8.67%
2018A$8.37 B-27.32%
2017A$11.52 B92.1%
2016A$5.99 B239.79%
2015A$1.76 B412.03%
2014A$0.34 B-72.82%
2013A$1.26 B56.99%
2012A$0.80 B29.04%
2011A$0.62 B-29.13%
2010A$0.88 B-0.23%
2009A$0.88 B17.84%
2008A$0.75 B-27.33%
2007A$1.03 B-5.66%
2006A$1.09 B2.06%
2005A$1.07 B16.63%
2004A$0.92 B36.15%
2003A$0.67 B-19.81%
2002A$0.84 B-53.88%
2001A$1.82 B49.59%
2000A$1.22 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Exelixis was reported to be:

A$17.01 Billion
by Nasdaq info icon info icon
A$17.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
A$147.24 B 761.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
A$177.94 B 941.54%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$371.89 B 2,076.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$158.30 B 826.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$260.32 B 1,423.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$731.07 B 4,178.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$220.51 B 1,190.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$26.26 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$0.78 B-95.41%๐Ÿ‡บ๐Ÿ‡ธ USA